Sumitomo Mitsui Trust Group
JAZZ icon

Sumitomo Mitsui Trust Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
6,600
+3,000
+83% +$524K ﹤0.01% 837
2025
Q4 		$612K Buy
+3,600
New +$552K ﹤0.01% 916
2024
Q3 		– Sell
-18,119
Closed -$1.93M – 1076
2024
Q2 		$1.93M Sell
18,119
-141,198
-89% -$15.5M ﹤0.01% 838
2024
Q1 		$19.2M Sell
159,317
-3,117
-2% -$382K 0.01% 716
2023
Q4 		$20M Sell
162,434
-1,177
-0.7% -$147K 0.01% 704
2023
Q3 		$21.2M Sell
163,611
-845
-0.5% -$113K 0.02% 687
2023
Q2 		$20.4M Sell
164,456
-9,807
-6% -$1.32M 0.02% 704
2023
Q1 		$25.5M Sell
174,263
-2,125
-1% -$314K 0.02% 677
2022
Q4 		$28.1M Buy
176,388
+521
+0.3% +$76.4K 0.02% 647
2022
Q3 		$23.4M Buy
175,867
+126
+0.1% +$19.2K 0.02% 679
2022
Q2 		$27.4M Sell
175,741
-5,424
-3% -$835K 0.02% 673
2022
Q1 		$28.2M Buy
+181,165
New +$26.3M 0.02% 668

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Sumitomo Mitsui Trust Group's JAZZ Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group increased its Jazz Pharmaceuticals (JAZZ) stake by 83% in Q1 2026, buying an estimated $524K and bringing the position to 6,600 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Sumitomo Mitsui Trust Group first reported a position in JAZZ in Q1 2022 and has held it in 12 quarters since. The position peaked at $28.2M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 6,600 shares of Jazz Pharmaceuticals worth $1.25M as of Q1 2026.
  • Sumitomo Mitsui Trust Group bought 3,000 Jazz Pharmaceuticals shares in Q1 2026, an estimated $524K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #837 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
  • Sumitomo Mitsui Trust Group's Jazz Pharmaceuticals position peaked at $28.2M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.